Patents Assigned to Solarea Bio, Inc.
  • Patent number: 12048722
    Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: July 30, 2024
    Assignee: Solarea Bio, Inc.
    Inventors: Gerardo V. Toledo, Maria Juliana Soto-Giron, Jinwoo Kim, Julie E. Button, Eric Michael Schott
  • Patent number: 12016891
    Abstract: This disclosure provides for compositions (e.g., pharmaceutical compositions, dietary supplements, medical foods and food stuff), comprising combinations of live microbe populations for the treatment and/or prevention of immune system disorders and conditions related to inflammation, including both pathogen assisted conditions and conditions that are independent of pathogens. Included with the present disclosure are methods for use of the compositions, and methods for selecting microbial entities to formulate the compositions of the disclosure.
    Type: Grant
    Filed: April 20, 2023
    Date of Patent: June 25, 2024
    Assignee: SOLAREA BIO, INC.
    Inventors: Eric Michael Schott, Gerardo V. Toledo, Maria Juliana Soto-Giron, Alicia Eve Ballok, Ryan Green, Mark Charbonneau
  • Patent number: 11980647
    Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures. Also described herein are methods and compositions for using probiotics and prebiotics for management of inflammation, and symptoms of menopause.
    Type: Grant
    Filed: November 7, 2022
    Date of Patent: May 14, 2024
    Assignee: SOLAREA BIO, INC.
    Inventors: Eric Michael Schott, Gerardo V. Toledo, Maria Juliana Soto-Giron
  • Patent number: 11938158
    Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures. Also described herein are methods and compositions for using probiotics and prebiotics for management of inflammation, and symptoms of menopause.
    Type: Grant
    Filed: March 9, 2023
    Date of Patent: March 26, 2024
    Assignee: Solarea Bio, Inc.
    Inventors: Eric Michael Schott, Maria Juliana Soto-Giron, Gerardo V. Toledo
  • Patent number: 11819524
    Abstract: Described herein are methods and compositions for using microbial agents (probiotics) and agents that promote growth of certain microbes (prebiotics) for management (including prevention and treatment) of musculoskeletal disorders, including osteoporosis, osteopenia, Paget's disease, stunting, osteoarthritis, osteomyelitis, and delayed or non-union fractures.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: November 21, 2023
    Assignee: Solarea Bio, Inc.
    Inventors: Gerardo V. Toledo, Eric Michael Schott, Maria Juliana Soto-Giron, Jinwoo Kim, Julie E. Button
  • Patent number: 11793841
    Abstract: The present invention relates to the identification of a group of microorganisms, which are relatively abundant in the microbial communities associated with fruits and vegetables typically consumed raw and therefore transient or permanent members of the human microbiota. The consumption of mixtures of these microbes at relevant doses will produce a beneficial effect in the host by reducing the propensity to diabetes, obesity and metabolic syndrome mediated in part by production of short chain fatty acids to enhance colonic butyrate production. Therapeutic methods of the invention involve the use of live microorganisms or metabolites derived from said microorganisms to establish a microbial composition in the mammalian host that will improve significantly the ability to control weight, reduce the onset of diabetes, obesity and metabolic syndrome, and improve overall health.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: October 24, 2023
    Assignee: SOLAREA BIO, INC.
    Inventors: Gerardo V. Toledo, Tracy Mincer, Jahir Mauricio Gutierrez Bugarin, Jillian DeWalt, Eric Schott, Maria Juliana Soto Giron
  • Patent number: 10596209
    Abstract: The present invention relates to the identification of a group of microorganisms, which are relatively abundant in the microbial communities associated with fruits and vegetables typically consumed raw and therefore transient or permanent members of the human microbiota. The consumption of mixtures of these microbes at relevant doses will produce a beneficial effect in the host by reducing the propensity to diabetes, obesity and metabolic syndrome mediated in part by production of short chain fatty acids to enhance colonic butyrate production. Therapeutic methods of the invention involve the use of live microorganisms or metabolites derived from said microorganisms to establish a microbial composition in the mammalian host that will improve significantly the ability to control weight, reduce the onset of diabetes, obesity and metabolic syndrome, and improve overall health.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: March 24, 2020
    Assignee: Solarea Bio, Inc.
    Inventors: Gerardo V. Toledo, Tracy Mincer, Jahir Mauricio Gutierrez Bugarin, Jillian DeWalt, Eric Schott, Maria Juliana Soto Giron